Acute profound thrombocytopenia associated with anaphylactic reaction after abciximab therapy during percutaneous coronary angioplasty

被引：12
|
作者：
Iakovou, Y [1 ]
Manginas, A [1 ]
Melissari, E [1 ]
Cokkinos, DV [1 ]
机构：
[1] Onassis Cardiac Surg Ctr, Dept Cardiol, Athens, Greece
来源：
CARDIOLOGY | 2001年 / 95卷 / 04期
关键词：
D O I：
10.1159/000047375
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：215 / 216
页数：2
相关论文
共 50 条
  • [21] Abciximab therapy as a bail-out procedure after transluminal coronary angioplasty
    Mahrholdt, H
    Haase, KK
    Baumbach, A
    Dirr, E
    Oberhoff, M
    Schröder, S
    Athanasiadis, A
    Karsch, KR
    ZEITSCHRIFT FUR KARDIOLOGIE, 2000, 89 (08): : 724 - 731
  • [22] Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction
    Raveendran, Ganesh
    Ting, Henry H.
    Best, Patricia J.
    Holmes, David R., Jr.
    Lennon, Ryan J.
    Singh, Mandeep
    Bell, Malcolm R.
    Long, Kirsten Hall
    Rihal, Charanjit S.
    MAYO CLINIC PROCEEDINGS, 2007, 82 (02) : 196 - 202
  • [23] ACUTE MYOCARDIAL-INFARCTION DURING CORONARY ANGIOPLASTY ASSOCIATED WITH HEPARIN-INDUCED THROMBOCYTOPENIA
    GUPTA, BK
    SAVAGE, MP
    BREST, AN
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1995, 35 (01): : 42 - 46
  • [24] PERCUTANEOUS CORONARY LASER BALLOON ANGIOPLASTY FOR ACUTE OCCLUSIONS DURING CONVENTIONAL ANGIOPLASTY
    GLATT, B
    MORICE, MC
    ROYER, T
    ROSENBLAT, E
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1992, 85 (11): : 1551 - 1557
  • [25] MANAGEMENT OF ACUTE OCCLUSION AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    VLIETSTRA, RE
    EUROPEAN HEART JOURNAL, 1989, 10 : 101 - 103
  • [26] PREVENTION OF ACUTE COMPLICATIONS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    BOURASSA, MG
    SCHWARTZ, L
    LESPERANCE, J
    EASTWOOD, C
    KAZIM, F
    THROMBOSIS RESEARCH, 1990, : 51 - 58
  • [27] Costs and effects in therapy for acute coronary syndromes: The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study
    van Hout, BA
    Bowman, L
    Zelinger, DJ
    Simoons, ML
    AMERICAN HEART JOURNAL, 1998, 135 (04) : S98 - S106
  • [28] Costs and effects in therapy for acute coronary syndromes: The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study
    van Hout, BA
    Bowman, L
    Zelinger, DJ
    Simoons, ML
    EUROPEAN HEART JOURNAL, 1998, 19 : D59 - D66
  • [29] Pre-hospital treatment with Abciximab in acute myocardial infarction with direct percutaneous transluminal coronary angioplasty
    Glatt, B
    Guyon, P
    Chevalier, B
    Royer, T
    Jullien, T
    Hennequin, B
    Herlin, C
    Sebbah, JL
    Belotte, F
    Dambrin, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 230A - 230A
  • [30] Antiplatelet Therapy and Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome and Thrombocytopenia
    Yusuf, Syed Wamique
    Iliescu, Cezar
    Bathina, Jaya D.
    Daher, Iyad N.
    Durand, Jean-Bernard
    TEXAS HEART INSTITUTE JOURNAL, 2010, 37 (03) : 336 - 340
12345